+12.7%
GSK vs STT
+47.3%
-34.7%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | STT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.4% | +3.2% | -0.8% | +2.0% |
| 7D | +4.9% | +0.9% | +4.0% | +4.8% |
| 30D | +10.8% | -2.3% | +13.2% | +11.1% |
| 3M | -1.8% | -7.0% | +5.2% | -1.2% |
| 6M | +4.1% | +15.5% | -11.4% | -0.5% |
| YTD | +7.9% | +35.6% | -27.7% | -1.0% |
| All | +12.7% | +47.3% | -34.7% | +3.3% |
Cumulative growth
Daily Returns
Daily percentage return beside STT.
Daily Out/Under-Performance
Portfolio return minus STT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × STT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded STT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling